1.How Useful the Combined Impedance-pH Monitoring Is for Evaluation of Refractory Reflux Symptoms?.
Journal of Neurogastroenterology and Motility 2011;17(3):327-328
No abstract available.
3.Novel Technique for Inducing Neural Crest Fate in Embryonic Stem Cells (Stem Cells 2009;27:2896-2905).
Journal of Neurogastroenterology and Motility 2011;17(3):322-323
No abstract available.
Embryonic Stem Cells
;
Neural Crest
4.Hypotonic Upper Esophageal Sphincter With Functional Esophagogastric Junction Obstruction in a Patient With Oropharyngeal and Esophageal Dysphagia.
Journal of Neurogastroenterology and Motility 2011;17(3):320-321
No abstract available.
Deglutition Disorders
;
Esophageal Sphincter, Upper
;
Esophagogastric Junction
;
Humans
5.Is a Patient With Asymptomatic Esophagitis Really Hyposensitive to Acid and Distention?.
Takahisa YAMASAKI ; Jiro WATARI ; Tadayuki OSHIMA ; Toshihiko TOMITA ; Hiroto MIWA
Journal of Neurogastroenterology and Motility 2011;17(3):318-319
No abstract available.
Esophagitis
;
Humans
6.How to Interpret Hydrogen Breath Tests.
Journal of Neurogastroenterology and Motility 2011;17(3):312-317
Hydrogen breath tests using various substrates like glucose, lactulose, lactose and fructose are being used more and more to diagnose small intestinal bacterial overgrowth (SIBO) and lactose or fructose malabsorption. Though quantitative culture of jejunal aspirate is considered as gold standard for the diagnosis of SIBO, hydrogen breath tests, in spite of their low sensitivity, are popular for their non-invasiveness. Glucose hydrogen breath test is more acceptable for the diagnosis of SIBO as conventionally accepted double-peak criterion on lactulose hydrogen breath test is very insensitive and recently described early-peak criterion is often false positive. Hydrogen breath test is useful to diagnose various types of sugar malabsorption. Technique and interpretation of different hydrogen breath tests are outlined in this review.
Breath Tests
;
Fructose
;
Glucose
;
Hydrogen
;
Intestine, Small
;
Irritable Bowel Syndrome
;
Lactose
;
Lactulose
7.Psychiatric Co-morbidity and Efficacy of Mirtazapine Treatment in Young Subjects With Chronic or Cyclic Vomiting Syndromes: A Case Series.
Journal of Neurogastroenterology and Motility 2011;17(3):305-311
The aim of this case report was to evaluate the psychiatric co-morbidity and efficacy of mirtazapine treatment in young subjects with chronic or cyclic vomiting syndromes. This is a case series of 8 young subjects (age range of 6-16 years, 11.12 +/- 3.52 years) who were referred or consulted to child psychiatry department. They were referred or consulted by pediatric gastroenterology or surgery departments for the presence of non-remitting and medically unexplained vomiting. They were investigated for co-morbid psychiatric disorders using a structured psychiatric interview. An open trial of mirtazapine was conducted for the treatment and/or prevention of vomiting. Primary outcome measure was Clinical Global Impression-Improvement scale. Subjects were diagnosed with chronic (n = 5) or cyclic (n = 3) vomiting syndromes. Duration of vomiting ranged from 6 months to 10 years (3.5 +/- 3.2 years). All subjects received multiple psychiatric diagnoses with anxiety disorders being the most frequent. Maximum mirtazapine dosage was 7.5-30 mg/day (16.00 +/- 6.16 mg/day). Three subjects showed complete remission and 5 subjects showed much to very much improvement in vomiting. Most frequent side effects were increased appetite, weight gain and sedation. Young subjects with chronic or cyclic vomiting may frequently suffer anxiety and/or depressive symptoms or disorders. Mirtazapine could be an effective treatment option for the treatment of vomiting and co-morbid anxiety or depressive disorders in these subjects. More systematic research are needed on this topic.
Anxiety
;
Anxiety Disorders
;
Appetite
;
Child
;
Child Psychiatry
;
Depression
;
Depressive Disorder
;
Gastroenterology
;
Gastrointestinal Diseases
;
Humans
;
Mianserin
;
Outcome Assessment (Health Care)
;
Vomiting
;
Weight Gain
8.Determinant of Anal Resting Pressure Gradient in Association With Continence Function.
Moo Kyung SEONG ; Ung Chae PARK ; Sung Il JUNG
Journal of Neurogastroenterology and Motility 2011;17(3):300-304
BACKGROUND/AIMS: Gradient of resting pressure across the anal canal, which is known to have a role in continence mechanism, has 2 components of determination; pressure and length factor of the anal canal. This study evaluates which factor between them plays more significant role for the determination of the gradient in association with continence function. METHODS: Anal manometric measurements of 69 patients with fecal incontinence and 60 controls were retrospectively reviewed. In addition to resting pressure gradient, typical manometric parameters such as maximum resting pressure, basal resting pressure, length of the anal canal, length of high pressure zone and relative position of highest pressure, which were measured with rapid pull-through technique were all contrasted. RESULTS: Demographics of the 2 groups were similar. Maximum resting pressures of patients with incontinence and controls were 59.1 +/- 28.3, 74.6 +/- 24.0 mmHg (P = 0.001), respectively. Basal resting pressures were 5.7 +/- 6.4 and 7.3 +/- 3.9 mmHg (P = 0.097), lengths of the anal canal were 35.8 +/- 9.1 and 38.1 +/- 8.3 mm (P = 0.133), lengths of high pressure zone were 21.2 +/- 6.7 and 23.3 +/- 6.5 mm (P = 0.091), relative positions of highest pressure were 69.2 +/- 10.6 and 70.1% +/- 14.9% (P = 0.717) and resting pressure gradients were 2.28 +/- 1.08 and 2.74 +/- 1.14 mmHg/mm (P = 0.019), respectively. Difference was significant in maximum resting pressure and resting pressure gradient, but not in length factors such as full length of the anal canal, length of high pressure zone and relative position of highest pressure. CONCLUSIONS: Proximal location of high pressure zone in incontinent patients is not definite and resting pressure gradient of the anal canal depends more on pressure factor than length factor in association with continence function.
Anal Canal
;
Demography
;
Fecal Incontinence
;
Humans
;
Manometry
;
Retrospective Studies
9.Are Food Constituents Relevant to the Irritable Bowel Syndrome in Young Adults?: A Rome III Based Prevalence Study of the Korean Medical Students.
Hyun Joo JUNG ; Moo In PARK ; Won MOON ; Seun Ja PARK ; Hyung Hun KIM ; Eun Ji NOH ; Gyu Jin LEE ; Joo Hoon KIM ; Dong Gyu KIM
Journal of Neurogastroenterology and Motility 2011;17(3):294-299
BACKGROUND/AIMS: Irritable bowel syndrome (IBS) is prevalent in general population. This study investigates the prevalence of IBS in medical college students in Korea as well as the influence of dietary habits and nutritional intake on IBS. METHODS: This study is a cross-sectional study of 319 students (239 males and 80 females, age 22.3 +/- 2.5 years) from the 6 grade levels of the Medical College in Korea. All students filled out a self-reported questionnaire for ROME III criteria. They also completed a questionnaire to validate dietary habits and food frequency in Korean. RESULTS: The overall prevalence of IBS was 29.2% without correlation to age, body mass index and grade level in Medical School. However, the prevalence was significantly higher in females than males (33/80 vs 60/239, P = 0.007). There were no significant differences between the IBS-group and the non-IBS group in aspect of nutrition. Not only the diet habits, but also the daily nutritional intake, and even the breakdown into the 12 micronutrients, yielded no significant differences between the 2 groups. CONCLUSIONS: Twenty-nine percent of the medical college students have IBS with a greater prevalence in females. The dietary habits and nutritional intake of the students might not be associated with IBS.
Body Mass Index
;
Cross-Sectional Studies
;
Female
;
Food Habits
;
Humans
;
Irritable Bowel Syndrome
;
Korea
;
Male
;
Micronutrients
;
Prevalence
;
Surveys and Questionnaires
;
Rome
;
Schools, Medical
;
Students, Medical
10.Effects of Histamine-2 Receptor Antagonists and Proton Pump Inhibitors on the Rate of Gastric Emptying: A Crossover Study Using a Continuous Real-Time 13C Breath Test (BreathID System).
Takashi NONAKA ; Takaomi KESSOKU ; Yuji OGAWA ; Kento IMAJYO ; Shogo YANAGISAWA ; Tadahiko SHIBA ; Takashi SAKAGUCHI ; Kazuhiro ATSUKAWA ; Hisao TAKAHASHI ; Yusuke SEKINO ; Eiji SAKAI ; Takashi UCHIYAMA ; Hiroshi IIDA ; Kunihiro HOSONO ; Hiroki ENDO ; Yasunari SAKAMOTO ; Koji FUJITA ; Masato YONEDA ; Tomoko KOIDE ; Hirokazu TAKAHASHI ; Chikako TOKORO ; Yasunobu ABE ; Eiji GOTOH ; Shin MAEDA ; Atsushi NAKAJIMA ; Masahiko INAMORI
Journal of Neurogastroenterology and Motility 2011;17(3):287-293
BACKGROUND/AIMS: The effects of Histamine-2 receptor antagonists and proton pump inhibitors on the gastrointestinal motility have not yet been sufficiently investigated. The aim of this study was to determine the effects of intravenous bolus administration of famotidine and omeprazole on the rate of gastric emptying using the continuous 13C breath test (BreathID system, Exalenz Bioscience Ltd, Israel). METHODS: Twelve healthy male volunteers participated in this randomized, 3-way crossover study. After fasting overnight, the subjects were randomly assigned to receive 20 mg of famotidine, 20 mg of omeprazole or 20 mL of saline alone by intravenous bolus injection before a test meal (200 kcal per 200 mL, containing 100 mg of 13C-acetate). Gastric emptying was monitored for 4 hours after the ingestion of test meal by the 13C-acetic acid breath test performed using the BreathID system. RESULTS: No significant differences in the calculated parameters, namely, the T1/2, Tlag, GEC, beta and kappa, were observed among the 3 test conditions. CONCLUSIONS: The study revealed that intravenous administration of gastric acid suppressant drugs had no significant influence on the rate of gastric emptying in comparison with that of saline alone as a placebo. Our results indicating the absence of any effect of either famotidine or omeprazole on accelerating the rate of gastric emptying suggest that both medications can be administered safely to patients suffering from hemorrhagic peptic ulcers who need to be kept nil by mouth from the viewpoint of possible acceleration of gastrointestinal motility in the clinical setting.
Acceleration
;
Administration, Intravenous
;
Breath Tests
;
Cross-Over Studies
;
Eating
;
Famotidine
;
Fasting
;
Gastric Acid
;
Gastric Emptying
;
Gastrointestinal Motility
;
Humans
;
Male
;
Meals
;
Mouth
;
Omeprazole
;
Peptic Ulcer
;
Proton Pump Inhibitors
;
Proton Pumps
;
Protons
;
Stress, Psychological